SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001479290-18-000009
Filing Date
2018-01-08
Accepted
2018-01-08 16:20:10
Documents
3
Period of Report
2018-01-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rvnc18188-k.htm 8-K 28114
2 EXHIBIT 99.1 rvnc1818exhibit991.htm EX-99.1 24612
3 newlogotagline.jpg GRAPHIC 29677
  Complete submission text file 0001479290-18-000009.txt   94774
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 18516654
SIC: 2834 Pharmaceutical Preparations